END 7-OH Act

Summary of the END 7-OH Act

The END 7-OH Act is a bill recently introduced in the U.S. House of Representatives. Based on its title, the bill appears to target 7-hydroxymitragynine (7-OH), a chemical compound found in kratom, a plant that has become increasingly popular as a supplement and alternative remedy. The "END" in the title likely stands for a phrase signaling the bill's intent to restrict, ban, or regulate this specific substance. Because no official description has been provided and the bill is in its earliest stages, the full details of exactly what actions it would require are not yet publicly available.

The bill has been referred to two House committees — the Committee on Energy and Commerce and the Committee on the Judiciary — which suggests it may involve both public health regulations and potential criminal or controlled substance laws. This dual referral is common for bills that deal with both the regulation of substances by agencies like the FDA and the legal consequences of manufacturing, selling, or possessing those substances.

If passed, this bill would most directly affect consumers who use kratom or 7-OH products, as well as businesses that manufacture, sell, or distribute them — including online retailers, supplement stores, and smoke shops. It could also affect researchers studying the compound and healthcare providers whose patients use it. At this early stage, the bill has not yet been voted on or advanced through committee, so its final form and impact remain to be determined.